Literature DB >> 19868628

EXPERIMENTAL STUDIES OF THE NASOPHARYNGEAL SECRETIONS FROM INFLUENZA PATIENTS : VII. SEROLOGICAL REACTIONS.

P K Olitsky1, F L Gates.   

Abstract

Cultivation of Bacterium pneumosintes in the collodion sac dialysate of a tissue medium produces an antigen suitable for serological tests. Injection of dialysate cultures of Bacterium pneumosintes into rabbits results in the production of antibodies demonstrable by agglutination, precipitation, complement fixation, and phagocytic reactions. Four strains of Bacterium pneumosintes, three from the first epidemic influenzal wave (1918-19) and one from the second (1920), show identical antigenic characters. The blood serum of rabbits experimentally injected with the glycerolated active material of rabbit passages contains specific agglutinins for Bacterium pneumosintes, whereas normal rabbit serum does not.

Entities:  

Year:  1922        PMID: 19868628      PMCID: PMC2128118          DOI: 10.1084/jem.35.4.553

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  2 in total

1.  EXPERIMENTAL STUDIES OF THE NASOPHARYNGEAL SECRETIONS FROM INFLUENZA PATIENTS : I. TRANSMISSION EXPERIMENTS WITH NASOPHARYNGEAL WASHINGS.

Authors:  P K Olitsky; F L Gates
Journal:  J Exp Med       Date:  1921-01-31       Impact factor: 14.307

2.  EXPERIMENTAL STUDIES OF THE NASOPHARYNGEAL SECRETIONS FROM INFLUENZA PATIENTS : IV. ANAEROBIC CULTIVATION.

Authors:  P K Olitsky; F L Gates
Journal:  J Exp Med       Date:  1921-05-31       Impact factor: 14.307

  2 in total
  2 in total

1.  EXPERIMENTAL STUDIES OF THE NASOPHARYNGEAL SECRETIONS FROM INFLUENZA PATIENTS : IX. THE RECURRENCE OF 1922.

Authors:  P K Olitsky; F L Gates
Journal:  J Exp Med       Date:  1922-10-31       Impact factor: 14.307

2.  EXPERIMENTAL STUDIES OF THE NASOPHARYNGEAL SECRETIONS FROM INFLUENZA PATIENTS : VII. FURTHER OBSERVATIONS ON THE CULTURAL AND MORPHOLOGICAL CHARACTERS OF BACTERIUM PNEUMOSINTES.

Authors:  P K Olitsky; F L Gates
Journal:  J Exp Med       Date:  1922-05-31       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.